Joseph Newhouse

Last updated
Joseph P. Newhouse
Born (1942-02-24) February 24, 1942 (age 81)
NationalityAmerican
Academic career
Institution Harvard University
Field Health economics
Alma mater Harvard University (Ph.D., 1969)
Harvard University (B.A., 1963)
Information at IDEAS / RePEc

Joseph P. Newhouse (born February 24, 1942) is an American economist and the John D. MacArthur Professor of Health Policy and Management at Harvard University, as well as the Director of the Division of Health Policy Research and of the Interfaculty Initiative on Health Policy. [1] [2] [3] At Harvard, he is a member of the four faculties at Harvard Kennedy School in Cambridge, Harvard Medical School in Boston, Harvard T.H. Chan School of Public Health in Boston, and Harvard Faculty of Arts and Sciences in Cambridge.

Contents

Prior to his joining the Faculty at Harvard, he worked for twenty years as an economist at the RAND Corporation, and served as a faculty member of the RAND Graduate School from 1972 to 1988. At RAND, he played a leading role in RAND Health Insurance Experiment. In 2008, he collaborated with the Oregon Health Study team. [4] [5]

He is a Fellow of the American Academy of Arts and Sciences, and an elected member of the National Academy of Medicine formerly the Institute of Medicine. He is also a Faculty Research Associate of the National Bureau of Economic Research.[ citation needed ] He was the Editor of the Journal of Health Economics for 30 years, which he founded in 1981. [6]

He has received the numerous awards such as the Victor R. Fuchs Lifetime Achievement Award from the American Society of Health Economists, the David Kershaw Prize from the Association for Public Policy Analysis and Management, the Distinguished Investigator Award from the Association for Health Services Research, the Kenneth J. Arrow award in Health Economics from the International Health Economics Association, the Zvi Griliches award for the best paper in Quarterly Journal of Economics, The Hans Sigrist Prize, and the Paul A. Samuelson Certificate of Excellence from TIAA-CREF. He was twice awarded article of the year by AcademyHealth. In 1988, he was awarded the Baxter Health Services Research Prize and the Administrator's Citation from the Health Care Financing Administration. He has also been awarded the Hans Sigrist Foundation Prize for distinguished scientific achievement; the American Risk and Insurance Association's Elizur Wright Award for an outstanding contribution to the literature on risk and insurance literature. [6]

He is the author of many journal articles and several books including "Free for All: Lessons from the RAND Health Insurance Experiment "Harvard University Press, 1993, and "Pricing the Priceless: A Health Care Conundrum" MIT Press, 2002. [6]

He was the founding director of the Health Policy Ph.D. program at Harvard University and chaired the committee that administers the program for 25 years. [7] He is the Principal Investigator of a National Institute of Aging T-32 grant for MD-PhD's in Health Policy, Economics, and Social and Behavioral Sciences. [8] He has chaired or been a member of 71 doctoral dissertation committees in his career.

The Economics of Quality in Health Care

Michael Kobernick Jillian Shank Jefferson Medical College

As a result of years of research with the RAND Corporation and Harvard University, Joseph Newhouse has become extremely passionate about the instability of our nation's health care system. In his 2002 article, [9] he describes the healthcare systems of the United States as “obtaining less value from the resources it uses than other industries”. Prior to proceeding with an explanation of Newhouse's issues that lead to poor performance, it is important to understand the definitions of quality from the Institute of Medicine (IOM) and in economic terms. The IOM defines quality as the gap between the actual and potential performance of the US Healthcare system. [10]

In economic terms, Alan M. Garber and Jonathan Skinner have explored the principles of productive and allocative inefficiency. [11] Productive efficiency refers to the impact of inputs like “physicians, nurses, hospital beds, and capital” on American health care and the authors ask if the impact is greater in other countries (more efficient). Allocative efficiency refers to the benefits from the “marginal dollar spent on health care” and asks the question do the benefits realized “exceed the opportunity cost of other goods” not purchased like raising salaries, a new car, or better education. [12] The authors found that “nearly all countries fall short of ideal in productive efficiency” and the United States system lags behind (is less efficient) other countries most of the time. [13] They found that the U.S. has a high degree of allocative inefficiency, when compared with other high-income countries. The causes are “high prices for inputs, poorly restrained incentives for overutilization, and a tendency to adopt expensive medical innovations rapidly, even when evidence of effectiveness is weak or absent”. [14]

Combining the quality definition by the IOM and economic terms, Newhouse suggests the reasons for poor this performance stem from the following: consumer ignorance, technological change, administered prices, the difficulty in assessing the performance of a given provider, and the role of the private sector. Consumer ignorance is associated with the inability to evaluate if the care provided is correct care and deferral of agency to the physician. The consumer is unable to assure high performance. In focusing on technology, Newhouse indicates that each health care system must keep up with new devices, medicine, and even abide by nationwide use of the EMR to make the most informed decisions for each individual. This rapid pace of change is often difficult to keep up with, resulting in poor quality. Administered prices are determined between the insurer and provider leading to the input cost adapting to the payment, not necessarily the needs of the patient or quality of care. Newhouse thinks a fixed price for goods and services might assure quality, as opposed to the DRG in which the hospital makes the most money by providing the minimum service. Measuring performance is difficult as many outcomes are subjective; without accurate measurement the ability to assess the provider is limited. Finally, Newhouse cites public sector policy, such as, creating barriers to entry into health care professions or using public funding for services result in politically based decisions often not in the best interest of overall quality.

Newhouse's endeavors successfully delineate the reasons for the quality chasm. He has a few suggestions: greater use of technology to provide better information to the physician during decision making, use of computer decision support systems, better health services research, and better financial incentive design and research.

Other researchers and health care planners have attempted ways of crossing the quality chasm by improving the organization of health care for individuals. Organizational improvements include the primary care medical home, accountable care organizations, and allowing consumers to share in the savings of health payments after selecting coverage that leads to lower costs and higher quality . Some think increasing government regulation may result in improved access to care, reducing social disparities, training of more primary care providers, and enhancing the verification of provider competence in new technologies. As projected by Newhouse, programs to validate the provision of evidence-based care will enhance the safety of health care, as well as, medication reconciliation, check lists in the operating rooms, and care transition management. [10]

Additional programs to address Newhouse's problems include payment reform in Medicare to restructure programs, offering a wider range of services, and moving from fee for service to fee for value, which then may result in enhanced engagement of the consumer.5 Increasing the roles and responsibilities of the independent payment advisory board may assist in payment reform as well, [15] in addition to utilizing an electronic medical record to develop reporting systems that may be used for physician and patient evaluation and care gap closure. Increased competition amongst health plans through an insurance exchange may lead to better quality and pricing. Newhouse does an excellent job of describing the problems surrounding the quality chasm and suggesting many interventions to try and cross it.

Related Research Articles

<span class="mw-page-title-main">Health economics</span> Branch of economics

Health economics is a branch of economics concerned with issues related to efficiency, effectiveness, value and behavior in the production and consumption of health and healthcare. Health economics is important in determining how to improve health outcomes and lifestyle patterns through interactions between individuals, healthcare providers and clinical settings. In broad terms, health economists study the functioning of healthcare systems and health-affecting behaviors such as smoking, diabetes, and obesity.

<span class="mw-page-title-main">Mark McClellan</span> American health economist (born 1963)

Mark Barr McClellan is the director of the Robert J Margolis Center for Health Policy and the Margolis Professor of Business, Medicine and Health Policy at Duke University. Formerly, he was a senior fellow and director of the Health Care Innovation and Value Initiative at the Engelberg Center for Health Care Reform at The Brookings Institution, in Washington, D.C. McClellan served as commissioner of the United States Food and Drug Administration under President George W. Bush from 2002 through 2004, and subsequently as administrator of the Centers for Medicare and Medicaid Services from 2004 through 2006.

The term managed care or managed healthcare is used in the United States to describe a group of activities intended to reduce the cost of providing health care and providing American health insurance while improving the quality of that care. It has become the predominant system of delivering and receiving American health care since its implementation in the early 1980s, and has been largely unaffected by the Affordable Care Act of 2010.

...intended to reduce unnecessary health care costs through a variety of mechanisms, including: economic incentives for physicians and patients to select less costly forms of care; programs for reviewing the medical necessity of specific services; increased beneficiary cost sharing; controls on inpatient admissions and lengths of stay; the establishment of cost-sharing incentives for outpatient surgery; selective contracting with health care providers; and the intensive management of high-cost health care cases. The programs may be provided in a variety of settings, such as Health Maintenance Organizations and Preferred Provider Organizations.

The RAND Health Insurance Experiment was an experimental study from 1974 to 1982 of health care costs, utilization and outcomes in the United States, which assigned people randomly to different kinds of plans and followed their behavior. Because it was a randomized controlled trial, it provided stronger evidence than the more common observational studies and concluded that cost sharing reduced "inappropriate or unnecessary" medical care (overutilization) but also reduced "appropriate or needed" medical care.

David Matthew Cutler is the Otto Eckstein Professor of Applied Economics at Harvard University. He was given a five-year term appointment of Harvard College Professor, which recognizes excellence in undergraduate teaching. He holds a joint appointment in the economics department and at Harvard Kennedy School and the Harvard School of Public Health, is a faculty member for the Harvard Center for Population and Development Studies, and serves as commissioner on the Massachusetts Health Policy Commission.

<span class="mw-page-title-main">Uwe Reinhardt</span>

Uwe Ernst Reinhardt was a professor of political economy at Princeton University and held several positions in the healthcare industry. Reinhardt was a prominent scholar in health care economics and a frequent speaker and author on subjects ranging from the war in Iraq to the future of Medicare.

Consumer-driven healthcare (CDHC), or consumer-driven health plans (CDHP) refers to a type of health insurance plan that allows employers and/or employees to utilize pretax money to help pay for medical expenses not covered by their health plan. These plans are linked to health savings accounts (HSAs), health reimbursement accounts (HRAs), or similar medical payment accounts. Users keep any unused balance or "rollover" at the end of the year to increase future balances or to invest for future expenses. They are a high-deductible health plan which has cheaper premiums but higher out of pocket expenses, and as such are seen as a cost effective means for companies to provide health care for their employees.

William C. Hsiao, an American economist, is the K.T. Li Research Professor of Economics at the Harvard T.H. Chan School of Public Health in Boston, Massachusetts. He is internationally recognized for his work on health care financing and social insurance.

<i>Crossing the Quality Chasm</i>

Crossing the Quality Chasm: A New Health System for the 21st Century is a report on health care quality in the United States published by the Institute of Medicine (IOM) on March 1, 2001. A follow-up to the frequently cited 1999 IOM patient safety report To Err Is Human: Building a Safer Health System, Crossing the Quality Chasm advocates for a fundamental redesign of the U.S. health care system.

Don E. Detmer is professor emeritus and professor of medical education at the University of Virginia.

<span class="mw-page-title-main">Mary Wakefield</span>

Mary Wakefield is an American nurse and health care administrator, who served in the Obama administration as acting United States Deputy Secretary of Health and Human Services from 2015 to 2017, and as head of the Health Resources and Services Administration from 2009 to 2015.

<span class="mw-page-title-main">Norman Daniels</span> American ethicist (born 1942)

Norman Daniels is an American political philosopher and philosopher of science, political theorist, ethicist, and bioethicist at Harvard University and the Harvard T.H. Chan School of Public Health. Before his career at Harvard, Daniels had built his career as a medical ethicist at Tufts University in Medford, Massachusetts, and at Tufts University School of Medicine, also in Boston. He also developed the concept of accountability for reasonableness with James Sabin, an ethics framework used to challenge the healthcare resource allocation in the 1990s.

There were a number of different health care reforms proposed during the Obama administration. Key reforms address cost and coverage and include obesity, prevention and treatment of chronic conditions, defensive medicine or tort reform, incentives that reward more care instead of better care, redundant payment systems, tax policy, rationing, a shortage of doctors and nurses, intervention vs. hospice, fraud, and use of imaging technology, among others.

Healthcare in the United States is largely provided by private sector healthcare facilities, and paid for by a combination of public programs, private insurance, and out-of-pocket payments. The U.S. is the only developed country without a system of universal healthcare, and a significant proportion of its population lacks health insurance.

Karen Davis is president of The Commonwealth Fund, a national philanthropy engaged in independent research on health and social policy issues. Davis is an economist, with a career in public policy and research. Before joining The Commonwealth Fund, she served as chairman of the Department of Health Policy and Management at The Johns Hopkins School of Public Health, where she also held an appointment as professor of economics. She served as deputy assistant secretary for health policy in the Department of Health and Human Services from 1977–1980, becoming the first woman to head a U.S. public health service agency.

Rashi Fein was an American health economist termed "a father of Medicare" in the United States and "an architect of Medicare", was Professor of Economics of Medicine, Emeritus, in the Department of Global Health and Social Medicine at Harvard Medical School, and the author of the book Medical Care, Medical Costs: The Search for a Health Insurance Policy.

Mark V. Pauly is an American economist whose work focuses on healthcare management and business economics. He is currently the Bendheim Professor in the Department of Health Care Management at the Wharton School of the University of Pennsylvania. Pauly is a former commissioner on the Physician Payment Review Commission, and has been a consultant to the Congressional Budget Office, the Office of the Secretary of the U.S. Department of Health and Human Services, the American Enterprise Institute, and served on the Medicare Technical Advisory Panel. He is also the Co-Editor-in-Chief of the Springer journal International Journal of Health Care Finance and Economics, and was formerly the Robert D. Eilers Professor from 1984 to 1989.

Yuting Zhang is a professor of health economics at the University of Melbourne, and an expert on economic evaluations of health policy and healthcare reforms. She is a journal editor, award recipient, and has written numerous articles in influential journals in her field.

Kate Ho is an economics professor at Princeton University. Since July 2018, Professor Ho has worked in partnership with Janet Currie, as a co-director of Princeton's Center for Health and Wellbeing. Ho specializes in the medical care market and its industrial organization with an emphasis on health insurers and hospitals. Ho studies how price effects and the conditions of care provided by hospitals. She has received several awards for her academic research. Professor Ho is a frequent keynote speaker at conferences across the United States of America.

Melinda Jean Beeuwkes Buntin is an American health economist and a professor at the Johns Hopkins Bloomberg School of Public Health and the Johns Hopkins Carey Business School. Previously, she was the Mike Curb Chair for Health Policy at Vanderbilt University, having served as a deputy assistant director for Health at the Congressional Budget Office.

References

  1. Joseph P. Newhouse Faculty profile page at Harvard Kennedy School of Government
  2. Joseph P. Newhouse Faculty profile page at Harvard Medical School's Department of Health Care Policy Archived 2010-11-04 at the Wayback Machine
  3. Joseph P. Newhouse Faculty profile page at Harvard T.H. Chan School of Public Health, Boston
  4. Oregon Health Study Archived 2012-06-26 at the Wayback Machine
  5. In Oregon, Test Case for Health Overhaul, Better Care at a Cost, By ANNIE LOWREY, New York Times, June 22, 2012
  6. 1 2 3 Frank, Richard G., and Thomas G. McGuire. "In recognition of Joseph P. Newhouse." (2007): 1071-1072.
  7. Joseph P. Newhouse Faculty profile page at Harvard Ph.D Program in Health Policy
  8. Department of Health and Human Services MD-PhD Training Program in Aging and the Social/Behavioral Sciences (T32)
  9. Newhouse, JP (2002). "Why is there a quality chasm?". Health Aff (Millwood). 21 (4): 13–25. doi: 10.1377/hlthaff.21.4.13 . PMID   12117124.
  10. 1 2 Institute of Medicine. (2014). Crossing the Quality Chasm: The IOM Health Care Quality Initiative. Washington: National Academy Press. Retrieved February 13, 2014 from "Crossing the Quality Chasm: The IOM Health Care Quality Initiative - Institute of Medicine". Archived from the original on 2011-09-28. Retrieved 2014-03-23.
  11. Garber, A.M.; Skinner, J. (2008). "Is American healthcare uniquely inefficient?" (PDF). Journal of Economic Perspectives. 2 (4): 27–50. doi:10.1257/jep.22.4.27. PMC   2659297 . PMID   19305645.
  12. Antos, J.; Bertko, J.; Chernew, M.; Cutler, D.; Goldman, D.; Kocher, B.; McClellan, M.; McGlynn, E.; Pauly, M.; Shortell, S. (2010). "Bending the curve through health reform implementation". American Journal of Managed Care. 16 (11): 804–12. PMID   21348552.
  13. Garber, A.; Skinner, J. (2008). "Is American Healthcare Uniquely Inefficient" (PDF). Journal of Economic Perspectives. 22 (4): 27–50. doi:10.1257/jep.22.4.27. PMC   2659297 . PMID   19305645.
  14. Institute of Medicine. (2001). Crossing the Quality Chasm: A New Health System for the Twenty-first Century. Washington: National Academy Press. Retrieved February 13, 2014 from "Archived copy" (PDF). Archived from the original (PDF) on 2015-02-21. Retrieved 2014-03-23.{{cite web}}: CS1 maint: archived copy as title (link)
  15. Newhouse, J (2002). "Why is there a Quality Chasm?". Health Affairs. 21 (4): 13–23. doi: 10.1377/hlthaff.21.4.13 . PMID   12117124.